Richard William Scalzo Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 21 hours ago
Richard William Scalzo has an estimated net worth of at least $10.0 million*, as of yesterday. They own 122,330 shares of DYN stock. They have sold 339,244 shares of DYN stock since 2021, for an estimated $8.7 million.
Richard William Scalzo $DYN SEC Form 4 Insider Trading
Richard William Scalzo has filed a total of 40 insider trades in $DYN since 2021. Their most recent trade was a sale of 1,343 shares, made on Mar 11, 2025. Their largest trade was a sale of 124,374 shares, made on Sep 06, 2024. We estimate that they now own 122,330 shares of $DYN, worth an estimated $1.3 million.
Insider Trading at $DYN
There have been a total of 331 insider trades reported at $DYN since 2021, with 3.6 million shares purchased and 8.5 million shares sold. The most active insider traders in $DYN stock have been Oxana Beskrovnaya, Susanna Gatti High, and Richard William Scalzo. The most recent trade was a sale of 143 shares reported by Johanna Friedl-Naderer (Chief Commercial Officer), made on Mar 13, 2025.
History of Insider Stock Trades by Richard William Scalzo
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 1,343 | Mar 11, 2025 | March 13, 2025, 4:08 p.m. |
![]() |
Sale | 917 | Mar 05, 2025 | March 7, 2025, 5:06 p.m. |
![]() |
Sale | 2,488 | Feb 18, 2025 | Feb. 18, 2025, 6:09 p.m. |
![]() |
Sale | 1,455 | Dec 11, 2024 | Dec. 11, 2024, 9:40 p.m. |
![]() |
Sale | 2,735 | Nov 18, 2024 | Nov. 18, 2024, 5:28 p.m. |
![]() |
Sale | 1,390 | Sep 18, 2024 | Sept. 19, 2024, 4:52 p.m. |
![]() |
Sale | 1,468 | Sep 11, 2024 | Sept. 11, 2024, 4:13 p.m. |
![]() |
Sale | 1,700 | Sep 06, 2024 | Sept. 10, 2024, 4:05 p.m. |
![]() |
Sale | 124,374 | Sep 06, 2024 | Sept. 10, 2024, 4:05 p.m. |
![]() |
Sale | 310 | Aug 19, 2024 | Aug. 20, 2024, 4:28 p.m. |
![]() |
Sale | 2,442 | Aug 19, 2024 | Aug. 20, 2024, 4:28 p.m. |
![]() |
Sale | 1,590 | Jun 10, 2024 | June 11, 2024, 7:28 p.m. |
![]() |
Sale | 1,331 | Jun 11, 2024 | June 11, 2024, 7:28 p.m. |
![]() |
Sale | 462 | May 16, 2024 | May 17, 2024, 9:04 p.m. |
![]() |
Sale | 2,126 | May 16, 2024 | May 17, 2024, 9:04 p.m. |
![]() |
Sale | 1,082 | Mar 11, 2024 | March 12, 2024, 9:57 p.m. |
![]() |
Sale | 1,590 | Mar 11, 2024 | March 12, 2024, 9:57 p.m. |
![]() |
Sale | 30,755 | Mar 08, 2024 | March 12, 2024, 9:57 p.m. |
![]() |
Sale | 55,208 | Mar 08, 2024 | March 12, 2024, 9:57 p.m. |
![]() |
Sale | 289 | Mar 08, 2024 | March 12, 2024, 9:57 p.m. |
![]() |
Sale | 2,273 | Mar 07, 2024 | March 11, 2024, 9:45 p.m. |
![]() |
Sale | 3,429 | Feb 29, 2024 | March 1, 2024, 10:37 p.m. |
![]() |
Sale | 8,747 | Mar 01, 2024 | March 1, 2024, 10:37 p.m. |
![]() |
Sale | 564 | Mar 01, 2024 | March 1, 2024, 10:37 p.m. |
![]() |
Sale | 13,000 | Jan 26, 2024 | Jan. 26, 2024, 8:47 p.m. |
![]() |
Sale | 13,000 | Jan 03, 2024 | Jan. 4, 2024, 10:46 p.m. |
![]() |
Sale | 2,376 | Dec 14, 2023 | Dec. 14, 2023, 5:59 p.m. |
![]() |
Sale | 1,380 | Dec 11, 2023 | Dec. 12, 2023, 6:35 p.m. |
![]() |
Sale | 681 | Dec 04, 2023 | Dec. 6, 2023, 7:13 p.m. |
![]() |
Sale | 1,872 | Dec 06, 2023 | Dec. 6, 2023, 7:13 p.m. |
![]() |
Sale | 1,290 | Sep 18, 2023 | Sept. 20, 2023, 4:49 p.m. |
![]() |
Sale | 1,397 | Sep 12, 2023 | Sept. 13, 2023, 7:53 p.m. |
![]() |
Sale | 1,390 | Jun 13, 2023 | June 15, 2023, 5:46 p.m. |
![]() |
Sale | 10,000 | Jun 15, 2023 | June 15, 2023, 5:46 p.m. |
![]() |
Sale | 40,000 | Jun 13, 2023 | June 15, 2023, 5:46 p.m. |
![]() |
Sale | 1,311 | Mar 14, 2023 | March 15, 2023, 5:51 p.m. |
![]() |
Sale | 312 | Dec 12, 2022 | Dec. 13, 2022, 6:06 p.m. |
![]() |
Sale | 308 | Mar 11, 2022 | March 14, 2022, 5:09 p.m. |
![]() |
Sale | 367 | Sep 20, 2021 | Sept. 21, 2021, 8 p.m. |
![]() |
Sale | 492 | Sep 21, 2021 | Sept. 21, 2021, 8 p.m. |
$DYN Executives and Stock Owners with Insider Trades
-
Oxana Beskrovnaya, Chief Scientific Officer
-
Susanna Gatti High, Chief Operating Officer
-
Richard William Scalzo, SVP, Head of Finance & Admin.
-
Jonathan Mcneill, Chief Business Officer
-
Wildon Farwell, Chief Medical Officer
-
Joshua T Brumm, CEO & President
-
Joshua T Brumm, See Remarks
-
Richard William Scalzo, See Remarks
-
Jonathan Mcneill, See Remarks
-
John Cox, CEO & President
-
Douglas Kerr, Chief Medical Officer
-
Johanna Friedl-Naderer, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.